CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating expenses:
Selling, general and administrative	$ 3,903	$ 3,125
Research and development	2,034	825
Change in fair value of contingent consideration	(4)	(3,488)
Total operating costs and expenses	5,933	462
Loss from operations	(5,933)	(462)
Other (loss) income:
Change in fair value of convertible notes	(8,727)	(1,631)
Change in fair value of warrants	4,656	86,729
Loss on issuance of warrants		(75,644)
Loss on extinguishment of debt	(76)
Loss on derivative liability	(1,743)
Other income, net	30	103
Total other (loss) income, net	(5,860)	9,557
(Loss) income before taxes	(11,793)	9,095
Net (loss) income	$ (11,793)	$ 9,095
Basic net (loss) income per share (in dollars per share)	$ (0.29)	$ 2.28
Diluted net (loss) income per share (in dollars per share)	$ (0.29)	$ 2.28
Weighted average shares of common stock outstanding used to compute basic net (loss) income per share	40,614,087	3,984,876
Weighted average shares of common stock outstanding used to compute diluted net (loss) income per share	40,614,087	3,984,876